English | Español
Patient Daily | Feb 4, 2026

Study maps separate impacts of genetics and environment on human immune system
Patient Daily | Feb 4, 2026

Researchers report success using fecal transplants to aid immunotherapy response in some cancers
Patient Daily | Feb 4, 2026

Lilly and Repertoire partner on T cell therapies in $1.9B autoimmune disease deal
Patient Daily | Feb 4, 2026

AstraZeneca announces $15 billion investment plan for cell therapies and manufacturing in China
Patient Daily | Feb 4, 2026

Sanofi sees dip in vaccine sales amid US policy changes but forecasts growth
Patient Daily | Feb 4, 2026

Roche targets third place in global obesity drug market after acquisitions
Patient Daily | Feb 4, 2026

Biotech investors focus on asset-centric deals amid shifting risks after JPM 2026
Patient Daily | Feb 4, 2026

Biotech IPO boom of 2021 faces reality check as sector recalibrates

Trending
+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug